전사체학 시장 보고서 : 유형, 기술, 용도, 최종사용자, 지역별(2024-2032년)

The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.

Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.

Transcriptomics Market Trends:

The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.

Breakup by Type:

Instruments

Consumables

Software

Services

Breakup by Technology:

Microarray

Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)

Sequencing Technologies

Breakup by Application:

Diagnostics and Disease Profiling

Drug Discovery

Others

Breakup by End User:

Academic and Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. What was the size of the global transcriptomics market in 2023?
• 2. What is the expected growth rate of the global transcriptomics market during 2024-2032?
• 3. What are the key factors driving the global transcriptomics market?
• 4. What has been the impact of COVID-19 on the global transcriptomics market?
• 5. What is the breakup of the global transcriptomics market based on type?
• 6. What is the breakup of the global transcriptomics market based on the technology?
• 7. What is the breakup of the global transcriptomics market based on the application?
• 8. What are the key regions in the global transcriptomics market?
• 9. Who are the key players/companies in the global transcriptomics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Transcriptomics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Software
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Services
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Microarray
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Sequencing Technologies
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Diagnostics and Disease Profiling
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Drug Discovery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Academic and Research Institutes
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Pharmaceutical Companies
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Biotechnology Companies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Agilent Technologies Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Becton Dickinson and Company
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 BGI Group
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
  • 15.3.4 Bio-Rad Laboratories Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Biospyder Technologies Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Illumina Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Nanostring Technologies Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
  • 15.3.8 Qiagen
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Roche Holding AG
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
  • 15.3.10 Takara Bio Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
  • 15.3.11 Thermo Fisher Scientific Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.